Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joseph M Arreguin"'
Publikováno v:
Future cardiology. 17(2)
Postmenopausal women have an increased risk of cardiovascular disease, which is believed to correlate with lower estrogen level. There are conflicting data regarding hormone replacement therapy (HRT) based on the timing of this therapy. After large r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78e29d1f174c6d6b60724db1bc08f67
https://pubmed.ncbi.nlm.nih.gov/33191784
https://pubmed.ncbi.nlm.nih.gov/33191784
Publikováno v:
Reviews in Cardiovascular Medicine. 16:68-73
Limitations of current antiplatelet therapies have led to the discovery of new antiplatelet agents with new modes of action. Vorapaxar has been developed as a thrombin receptor antagonist. This drug works against the protease-activated receptor 1 (PA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8acd05444cb89381d45a39f1e9f5de
https://doi.org/10.3909/ricm0754
https://doi.org/10.3909/ricm0754
Publikováno v:
Cardiovascular Pharmacology: Open Access.
Antiplatelet therapy plays an integral role in the treatment of ischemic heart disease, the leading cause of death in most Western Countries. Previously, the classes of antiplatelet drugs that proved effective included aspirin, thienopyridines (e.g.t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5a14d28f9646ad070e140db2d58e784
https://doi.org/10.4172/2329-6607.1000128
https://doi.org/10.4172/2329-6607.1000128